Overview
This study evaluates the dose-response relationship of Dexmedetomidine (DEX) in reducing the incidence and severity of postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) in elderly patients. The study compares different doses of DEX against a fentanyl control group in patients undergoing major lower limb orthopedic surgery under general anesthesia to determine the optimal dosage for cognitive protection.
Eligibility
Inclusion Criteria:
- Elderly surgical patients.
- ASA physical status grade II-III.
- Planned major lower limb orthopedic surgery.
Exclusion Criteria:
- pre-existing dementia or drug allergies


